@LargusAverta
It appears quite straightforward to me. I've simply highlighted that AGY have previously set a clear precedent by reporting grade and production output, and there has been a noticeable shift in that practice. I've presented a logical reason for why this change is more likely negative than not. In contrast, your perspective seems to suggest that they just "chose not to include it" without offering supporting evidence or rationale. I'd encourage you to reconsider the logical or reasonable aspects of your stance, but I understand that critical thinking may not be your strong suit.
By the way, the repetition game seems to stem from your impulsive inclination to challenge opinions you disagree with. If you prefer not to engage in this back and forth, perhaps refraining from tagging/commenting would be a more suitable choice.
- Forums
- ASX - By Stock
- AGY
- Ann: Quarterly Activities Report - December 2023
Ann: Quarterly Activities Report - December 2023, page-130
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.6¢ |
Change
0.001(2.86%) |
Mkt cap ! $52.41M |
Open | High | Low | Value | Volume |
3.7¢ | 3.7¢ | 3.6¢ | $74.60K | 2.022M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 597597 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 686934 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 597597 | 0.036 |
30 | 3434953 | 0.035 |
17 | 2085124 | 0.034 |
11 | 1388935 | 0.033 |
4 | 715000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 686934 | 8 |
0.038 | 1507777 | 6 |
0.039 | 1495481 | 8 |
0.040 | 742475 | 5 |
0.041 | 710322 | 6 |
Last trade - 13.32pm 12/11/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online